Skip to main content

Table 3 Spearman correlation and multiple regression analysis between pH values and the main clinical and metabolic features in all population and in the two groups with type 1 diabetes before (Group I) and during (Group II) COVID-19 pandemic

From: Peculiar characteristics of new-onset Type 1 Diabetes during COVID-19 pandemic

  Spearman Correlation Multiple regression analysis
  Whole population Group I Group II Group I Group II
  Beta P Beta P Beta P Beta P Beta P
Age (years) 0.09 0.20 0.02 0.79 0.26 0.10     
Weight-SDS 0.28  < 0.001 0.24 0.005 0.24 0.13 0.32 0.04 -0.08 0.70
Height-SDS 0.12 0.11 0.07 0.39 0.12 0.44     
BMI-SDS 0.19 0.01 0.14 0.09 0.21 0.19 -0.29 0.06 0.09 0.61
Glycemia (mg/dL) -0.28  < 0.001 -0.23 0.007 -0.47 0.002 -0.14 0.24 -0.14 0.43
HbA1c (mmol/mol) -0.33  < 0.001 -0.40  < 0.001 -0.37 0.01 -0.15 0.25 -0.14 0.37
C-peptide (ng/mL) 0.35  < 0.001 0.33 0.001 0.31 0.04 0.25 0.05 0.41 0.008
GAD Ab (U/ml) -0.01 0.90 -0.04 0.61 0.06 0.73     
IA2 Ab (U/ml) -0.12 0.15 -0.15 0.11 -0.15 0.35     
TSH (µUI/ml) -0.07 0.37 -0.10 0.29 -0.14 0.36     
FT4 (ng/dL) 0.04 0.63 -0.09 0.34 -0.10 0.53     
Total Cholesterol (mg/dL) 0.01 0.88 0.04 0.63 0.014 0.93     
HDL Cholesterol (mg/dL) 0.11 0.23 -0.002 0.96 0.36 0.03 0.054 0.67 0.54 0.01
LDL Cholesterol (mg/dL) 0.08 0.46 0.16 0.31 0.19 0.27     
Tryglicerides (mg/dL) -0.15 0.07 -0.03 0.72 -0.43 0.009 -0.05 0.65 -1.84 0.01
TG/HDL ratio -0.23 0.01 -0.16 0.89 -0.51 0.002 -0.06 0.6 1.78 0.03
  1. Legend Significant values P ≤ 0.05. BMI-SDS Standard Deviation Scores-Body Mass Index; HbA1c Hemoglobin A1c. IA2 Tyrosine Phosphatase antibodies IA-2. TSH  Thyroid-Stimulating Hormone. fT4 free-Thyroxine.